# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 9: Amendment to regulation C17

Extent: E+W+S+N.I.

In regulation C17(1) (guidelines on good manufacturing practice and good distribution practice), for “Great Britain” substitute “the United Kingdom”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/9 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-9
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.